ZNTL
NASDAQ · Biotechnology
Zentalis Pharmaceuticals Inc
$4.22
-0.78 (-15.60%)
Open$4.68
Previous Close$5.00
Day High$4.83
Day Low$4.01
52W High$6.95
52W Low$1.21
Volume—
Avg Volume899.9K
Market Cap355.93M
P/E Ratio—
EPS$-1.91
SectorBiotechnology
Analyst Ratings
Buy
16 analysts
Price Target
+541.9% upside
Current
$4.22
$4.22
Target
$27.09
$27.09
$17.95
$27.09 avg
$27.14
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 72.61M | 27.61M | 25.42M |
| Net Income | -178,578,310 | -2,223,610 | -1,538,415 |
| Profit Margin | -246.0% | -8.1% | -6.1% |
| EBITDA | -204,495,165 | -3,072,165 | -2,609,903 |
| Free Cash Flow | — | -1,433,660 | -1,157,693 |
| Rev Growth | — | +21.3% | +16.0% |
| Debt/Equity | — | 0.13 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |